PharVision Advisers’s TPG RE Finance Trust TRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,932
Closed -$117K 132
2026
Q1
$117K Buy
+14,932
New +$129K 1.18% 35
2025
Q1
Sell
-54,131
Closed -$460K 513
2024
Q4
$460K Buy
+54,131
New +$472K 0.39% 55

Other funds holding TRTX

PharVision Advisers's TRTX Position: Q2 2026 in Review

PharVision Advisers sold out of TPG RE Finance Trust (TRTX) in Q2 2026, closing a stake of 14,932 shares — an estimated $117K sold.

PharVision Advisers first reported a position in TRTX in Q4 2024 and held it in 2 quarters. The position peaked at $460K in Q4 2024. 154 funds tracked by Wall St. Rank hold TRTX as of Q2 2026.

  • PharVision Advisers reported no remaining TPG RE Finance Trust position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 14,932 TPG RE Finance Trust shares in Q2 2026, an estimated $117K.
  • PharVision Advisers first reported a position in TPG RE Finance Trust in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's TPG RE Finance Trust position peaked at $460K in Q4 2024.
  • 154 funds tracked by Wall St. Rank held TPG RE Finance Trust as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.